Myocardial MIBG scintigraphy is established in the diagnosis and differential diagnosis of Parkinson's disease (PD). Numerous studies address the pathophysiological impact of myocardial MIBG scintigraphy: the myocardial MIBG uptake correlates with the clinical phenotype of PD; the background of this phenomenon is unclear. Furthermore MIBG scintigraphy enables to study the extracranial Lewy body type-degeneration. In combination with cerebral dopamine transporter imaging, MIBG scintigraphy allows to correlate cerebral and extracranial Lewy body type-degeneration in PD
Cardiac sympathetic dysfunction was investigated using 123I-metaiodobenzylguanidine (MIBG) myocardia...
A decreased cardiac 123I-metaiodobenzylguanidine (123I-MIBG) uptake has been used as a powerful tool...
Objectives—123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is clini-cally used to estima...
OBJECTIVE: Differential diagnosis between Parkinson's disease (PD) and other Parkinsonism using clin...
INTRODUCTION: Dopamine transporter imaging and myocardial 123I-metaiodobenzylguanidine (123I-MIBG) s...
Metaiodobenzylguanidine (MIBG) was developed initially as a tracer for oncological imaging; when lab...
Metaiodobenzylguanidine (MIBG) was developed initially as a tracer for oncological imaging; when lab...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used t...
Myocardial scintigraphy with meta-iodo-benzyl-guanidine (123I cMIBG) has been studied in Parkinson's...
The purpose of this study was to investigate myocardial uptake of 123I-metaiodobenzylguanidine (MIBG...
Lewy body-related disorders are characterized by the presence of Lewy bodies and Lewy neurites, whic...
Meta-iodbenzylguanidine scintigraphy (MIBG scintigraphy) shows reduced uptake in idiopathic Parkinso...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
(123) I-meta-iodobenzylguanidine ((123) I-MIBG) myocardial scintigraphy is considered reliable in di...
Cardiac sympathetic dysfunction was investigated using 123I-metaiodobenzylguanidine (MIBG) myocardia...
A decreased cardiac 123I-metaiodobenzylguanidine (123I-MIBG) uptake has been used as a powerful tool...
Objectives—123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is clini-cally used to estima...
OBJECTIVE: Differential diagnosis between Parkinson's disease (PD) and other Parkinsonism using clin...
INTRODUCTION: Dopamine transporter imaging and myocardial 123I-metaiodobenzylguanidine (123I-MIBG) s...
Metaiodobenzylguanidine (MIBG) was developed initially as a tracer for oncological imaging; when lab...
Metaiodobenzylguanidine (MIBG) was developed initially as a tracer for oncological imaging; when lab...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used t...
Myocardial scintigraphy with meta-iodo-benzyl-guanidine (123I cMIBG) has been studied in Parkinson's...
The purpose of this study was to investigate myocardial uptake of 123I-metaiodobenzylguanidine (MIBG...
Lewy body-related disorders are characterized by the presence of Lewy bodies and Lewy neurites, whic...
Meta-iodbenzylguanidine scintigraphy (MIBG scintigraphy) shows reduced uptake in idiopathic Parkinso...
Background 123I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for differe...
(123) I-meta-iodobenzylguanidine ((123) I-MIBG) myocardial scintigraphy is considered reliable in di...
Cardiac sympathetic dysfunction was investigated using 123I-metaiodobenzylguanidine (MIBG) myocardia...
A decreased cardiac 123I-metaiodobenzylguanidine (123I-MIBG) uptake has been used as a powerful tool...
Objectives—123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is clini-cally used to estima...